Business Wire

ASC

Share
Peking University and the Chinese University of Hong Kong Triumph at 10th ASC Finals, Claiming Top Prizes

The 10th ASC Student Supercomputer Challenge (ASC) Finals recently concluded at the University of Science and Technology of China (USTC) in Hefei. For the onsite competition, Peking University emerged as the overall Champion, while USTC secured the Silver Prize and e Prize, marking a remarkable achievement. Zhejiang University was honored with the Highest LINPACK award, alongside several other teams who garnered prestigious honors. In the virtual competition, the team from the Chinese University of Hong Kong emerged as the champion, while the teams from the Chinese University of Hong Kong, National Tsing Hua University, and Kasetsart University were recognized with the Application Innovation Award.

Over 300 teams from universities worldwide participated in the 10th ASC Student Supercomputer Challenge. Following the preliminary contests, the Top 24 teams advanced to the finals. Among them, the Top 20 teams from the Chinese mainland competed onsite, while others engaged in virtual participation through the AWS cloud computing platform.

During the finals, teams showcased their prowess by designing and constructing cluster systems with a maximum power consumption of 3,000 W. Furthermore, they were tasked with running and optimizing cutting-edge scientific and engineering applications, such as HPL and HPCG benchmarks, Large Language Model, DeePMD, WRF-Hydro, and FVCOM. Remarkably, the 10th ASC featured a group competition, with 24 teams divided into 4 groups, tackling the current application of random quantum circuit sampling simulation.

The competition reached its pinnacle with Peking University ultimately clinching the coveted Champion title. The team demonstrated exceptional performance across various tasks, including WRF-Hydro and DeePMD, showcasing profound expertise in comprehensive supercomputing systems, applications, and outstanding optimization abilities. Meanwhile, the USTC team secured the Silver Prize, excelling in tasks such as Large Language Model and HPL&HPCG benchmarks.

USTC's team delivered outstanding results in the challenging Large Language Model task, employing cutting-edge large model parallel strategies, computing acceleration algorithms, and video memory optimization techniques. Their considerations of training speed and loss-convergence led to the team's remarkable performance, earning them the esteemed e Prize.

Zhejiang University's team, operating within the specified 3,000W power consumption limit, attained an impressive floating-point performance of 109 TFLOPs, ultimately securing them the Highest LINPACK award.

A collaborative effort by the Southern University of Science and Technology, Lanzhou University, Shanghai Jiao Tong University, Qilu University of Technology, and the Chinese University of Hong Kong resulted in efficient optimization of random quantum circuit sampling simulation. Their commendable efforts were rewarded with the Group Competition Award.

Furthermore, Qinghai University's outstanding performance earned them the Application Innovation Award.

Jack Dongarra, Member of US National Academy of Engineering, winner of the Turing Award, Distinguished Professor at the Oak Ridge National Laboratory and the University of Tennessee, and ASC Advisory Committee Chair said in the 10th ASC Student Supercomputer Challenge Finals’ closing ceremony, "The goal of the ASC Student Supercomputer Challenge is to foster the next generation of young talent, to inspire exploration, innovation, and collaboration in supercomputing and AI. Your efforts in designing, building, tuning, and optimizing your HPC systems, benchmarks and real scientific applications with a 3 kilowatt power cap are truly inspirational."

About ASC

The ASC Student Supercomputer Challenge stands as the world's most extensive competition in student supercomputing, expertly organized and sponsored by the Asia Supercomputer Community with support from esteemed institutions and experts across Asia, Europe, and America. ASC's primary goals encompass fostering international exchange and training for budding supercomputing talents, enhancing applications and research capabilities in the field, propelling the advancement of supercomputing technologies, and stimulating technical and industrial innovation. Since its inception in 2012, the ASC Student Supercomputer Challenge has attracted close to 10,000 undergraduate participants hailing from all corners of the globe. Learn more about ASC at http://asc-events.org/

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230518005351/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Enginzyme and AGC Create Scalable Process for Key mRNA Ingredient12.1.2026 06:00:00 CET | Press release

At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹ΨTP). The rapid growth of mRNA-based vaccines and therapeutics has driven significant demand for modified nucleotides like m¹ΨTP, which enhances mRNA stability and expression, while reducing immunogenicity. Enginzyme is a deep-tech company delivering optimized biomanufacturing solutions through cell-free enzyme engineering technology. AGC Inc. is a leading global player in fields spanning from architectural glass to chemicals and life science. AGC Inc. provides services in a wide range of life science fields, from synthetic pharmaceuticals and agrochemicals, to biopharmaceuticals and leading-edge cell and gene therapies, as well as messenger RNAs. The presentation in November detailed the latest collaboration between the companies, with a focus on the biomanufacturing of nucleotides for mRNA therapy,

Ant International Partners with Google’s Universal Commerce Protocol to Expand AI Capabilities12.1.2026 02:15:00 CET | Press release

Ant International, a leading global payment, digitisation, and financial technology provider, is collaborating on the launch of Google’s Universal Commerce Protocol (UCP), a new open standard for agentic commerce that works across the entire shopping journey — from discovery and buying to post-purchase support. UCP establishes a common language for agents and systems to operate together across consumer surfaces, businesses, and payment providers to enable commerce. So instead of requiring unique connections for every individual agent, UCP enables all agents to interact easily. UCP is built to work across verticals and is compatible with existing industry protocols like Agent2Agent (A2A), Agent Payments Protocol (AP2), and Model Context Protocol (MCP). “For agentic commerce to scale, it’s critical for the industry to align on a common set of standards. We are proud to have Ant International endorse the Universal Commerce Protocol as the foundation for that future,” said Ashish Gupta, VP

Torq Secures $140M Series D at $1.2B Valuation to Lead the AI SOC and Agentic AI Era11.1.2026 17:59:00 CET | Press release

Fueled by Massive Customer Adoption of AI Agents, Torq Scales the World’s First True AI SOC Platform and Accelerates Expansion into the U.S. Federal Market Torq, the established Agentic AI security operations pioneer, today announced it has closed a massive $140 million Series D funding round, propelling its valuation to $1.2 billion and total funding to $332M. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112510774/en/ Led by Merlin Ventures—a leading cybersecurity fund renowned for its deep access to the U.S. commercial and Public Sector markets—with participation from all existing investors, including Evolution Equity Partners, Notable Capital, Bessemer Venture Partners, Insight Ventures Partners, and Greenfield Partners, this capital injection is a definitive investment in the future of security. Torq is driving the industry’s critical shift: the complete transformation of the Security Operations Center (SOC) through

Andersen udvider sine kompetencer med tilføjelsen af Scimitar9.1.2026 21:44:00 CET | Pressemeddelelse

Andersen Consulting har indgået en samarbejdsaftale med Scimitar, der er et firma med fokus på at accelerere innovation i biovidenskabsbranchen. Scimitar, der har hovedkvarter i USA, et førende konsulenthus inden for strategieksekvering for biovidenskabsbranchen. Virksomheden er specialiseret i design af driftsmodeller, digital transformation og organisatorisk forandring. Scimitar samarbejder med medicinal- og biotech-virksomheder om at accelerere innovation, styrke den driftsmæssige eksekvering og sikre compliance gennem hele produkters livscyklus. Deres praktiske og samarbejdsorienterede tilgang sikrer løsninger, der ikke blot er formålstjenlige, men også skalerbare. "Virksomheder inden for biovidenskabsbranchen befinder sig i en tid med hurtige videnskabelige fremskridt, stigende regulatorisk kompleksitet og et voksende behov for operationel agilitet, samtidig med at de holdes op mod de højeste standarder for patientsikkerhed og dataintegritet," udtaler Ramy Khalil, CEO i Scimitar.

Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release

Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye